Journals / Klinik Tıp Pediatri Dergisi / 2017 / Cilt: 9 Sayı: 6

Diagnosis And Treatment Of Allergic Rhinitis In Children: Practical Approach

Çocuklarda Alerjik Rinitin Tanı ve Tedavisi: Pratik ve Güncel Yaklaşım

Pages
28–40
Publication Date
2017-11-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper reviews the diagnosis and treatment strategies of allergic rhinitis in the light of recent studies and guidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract Allergic rhinitis is an allergic disease, mediated by type I allergic mechanisms.
📊
Key Findings & Data:It is an inflammation of the nasal membranes.
💡
Conclusion & Impact:This paper reviews the diagnosis and treatment strategies of allergic rhinitis in the light of recent studies and guidelines.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Alerjik rinit · tanı · çevre önlemleri

Abstract

Abstract Allergic rhinitis is an allergic disease, mediated by type I allergic mechanisms. It is an inflammation of the nasal membranes. Characteristic clinical findings are sneezing, nasal congestion, nasal itching and rhinorrhea, in any combination. Laboratory tests used in the diagnosis of allergic rhinitis include allergy skin tests, specific IgE measurements, and imaging studies. The management of allergic rhinitis consists of the environmental control, pharmacologic management and immunotherapy. This paper reviews the diagnosis and treatment strategies of allergic rhinitis in the light of recent studies and guidelines.

Özet

Öz Allerjik rinit, tip I alerji mekanizmalarının neden olduğu bir alerjik hastalıktır. Nazal membranların inflamasyonudur. En önemli klinik bulguları hapşırık, burun tıkanıklığı ve burun akıntısıdır, birkaçı bir arada görülebilir. Tanısı için en çok başvurulan testler alerji deri testleri, spesifik IgE ölçümleri ve görüntüleme çalışmalarıdır. Alerjik rinitin tedavisinde çevre kontrolü, farmakolojik tedavi ve immünoterapidir. Bu yazıda alerjik rinitin tanı ve tedavi stratejileri yeni araştırmalar ve rehberler ışığında ele alınmaktadır.

🔖

Cite This Article

Güler, P. D. N. (2017). Diagnosis And Treatment Of Allergic Rhinitis In Children: Practical Approach. Klinik Tıp Pediatri Dergisi, Cilt: 9 Sayı: 6, 28–40. https://ajindex.com/articles/1595020

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (71)

  1. Kaynaklar 1.Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhini-tis and its impact on asthma. J Allergy Clin Immunol 2001
  2. 108 (Suppl. 5): S147–S334. 2.International Consensus Report on Diagnosis and Manage-ment of Rhinitis. International Rhinitis Management WorkingGroup. Allergy 1994
  3. 49 (Suppl. 19): 1–34. 3.Fokkens WJ. Thoughts on the pathophysiology of nonallergicrhinitis. Curr Allergy Asthma Rep 2002
  4. 203–209. 4.Fokkens W, Lund V, Bachert C, et al. EAACI position paperon rhinosinusitis and nasal polyp’s executive summary. Allergy2005
  5. 583–601. 5.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998
  6. 463–68. 6.Van-Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. EAACIPosition paper. Allergy 2000
  7. 116–34. 7.Bousquet J, Khaltaev N, Cruzz AA, et al. Allergic Rhinitis andIts Impact on Asthma (ARIA) 2008 update (in collaborationwith the World Health Organization, GA(2)LEN and AllerGen).Allergy 2008
  8. : 8-160.8.Tuncer A, Yüksel H. Ulusal Alerji Tanı ve tedavi Rehberi. Ulu-sal Allerji ve İmmunoloji Derneği, 2012. 9.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998
  9. 463–68. 10.Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol2003
  10. 111 (Suppl. 2): S520–S529. 11.van Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. Euro-pean Academy of Allergology and Clinical Immunology. Al-lergy 2000
  11. 116–34. 12.Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pol-lutants enhance rhinoconjunctivitis symptoms in pollen aller-gic individuals. Ann Allergy Asthma Immunol 2001
  12. 311–18. 13.Nascimento Silva M, Naspitz C, Sole D. Evaluation of qua-lity of life in children and teenagers with allergic rhinitis: adap-tation and validation of the Rhinoconjunctivitis Quality of LifeQuestionnaire (RQLQ). Allergol Immunopathol (Madr) 2001
  13. 111–18. 14.Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validati-on of the standardized version of the Rhinoconjunctivitis Qua-lity of Life Questionnaire. J Allergy Clin Immunol 1999
  14. 364–69. 15.Spector SL, Nicklas RA, Chapman JA, et al. Symptom seve-rity assessment of allergic rhinitis: part 1. Ann Allergy Asth-ma Immunol 2003
  15. 105–14. 16.Clement PA, Gordts F. Consensus report on acoustic rhino-metry and rhinomanometry. Rhinology 2005
  16. 169–79. 17.Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxi-de in objective evaluation of chronic rhinosinusitis therapy.Allergy 2006
  17. 717–24. 18.Litvyakova LI, Baraniuk JN. Nasal provocation testing: a re-view. Ann Allergy Asthma Immunol 2001
  18. 355–64. 19.Moll B, Klimek L, Eggers G, Mann W. Comparison of olfac-tory function in patients with seasonal and perennial allergicrhinitis. Allergy 1998
  19. 297–301. 20.Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according toARIA guidelines. Allergy 2007
  20. 367–72. 21.Yorgancıoğlu A, Özdemir C, Kalaycı Ö, et al
  21. WHO Collabo-rating Center on Asthma and Rhinitis. [ARIA (Allergic Rhi-nitis and its Impact on Asthma) achievements in 10 years andfuture needs]. Tuberk Toraks 2012
  22. Barnes K, Marsh D. The genetics and complexity of allergyand asthma. Immunol Today 1998
  23. 325–32. 23.Kurz T, Altmueller J, Strauch K, et al. A genome-wide scre-en on the genetics of atopy in a multiethnic European popu-lation reveals a major atopy locus on chromosome 3q21.3. Al-lergy 2005
  24. 192–99. 24.Strachan DP. Is allergic disease programmed in early life? [edi-torial
  25. comment]. Clin Exp Allergy 1994
  26. 603–605. 25.von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. In-creasing prevalence of hay fever and atopy among childrenin Leipzig, East Germany. Lancet 1998
  27. 862–66. 26.Stazi MA, Sampogna F, Montagano G, Grandolfo ME, CouilliotMF, Annesi Maesano I. Early life factors related to clinical ma-nifestations of atopic disease but not to skin prick test positivityin young children. Pediatr Allergy Immunol 2002
  28. 105–12. 27.Bjorksten F, Suoniemi I, Koski V. Neonatal birch pollen con-tact and subsequent allergy to birch pollen. Clin Allergy 1980
  29. 585–91. 28.Tedeschi A, Barcella M, Bo GA, Miadonna A. Onset of allergyand asthma symptoms in extra European immigrants to Mi-lan, Italy: possible role of environmental factors. Clin Exp Al-lergy 2003
  30. 449–54. 29.Stewart GA, Thompson PJ. The biochemistry of common ae-roallergens. Clin Exp Allergy 1996
  31. 1020–44. 30.Boulet LP, Turcotte H, Laprise C, et al. Comparative degreeand type of sensitization to common indoor and outdoor al-lergens in subjects with allergic rhinitis and/or asthma. ClinExp Allergy 1997
  32. 52–59. 31.Braun-Fahrlander C, Wuthrich B, Gassner M, et al. Valida-tion of a rhinitis symptom questionnaire (ISAAC core questi-ons) in a population of Swiss school children visiting the scho-ol health services. SCARPOL team. Swiss Study on Childho-od Allergy and Respiratory Symptom with respect to Air Pol-lution and Climate. International Study of Asthma and Aller-gies in Childhood. Pediatr Allergy Immunol 1997
  33. 75–82. 32.Gergen PJ, Turkeltaub PC. The association of individual al-lergen reactivity with respiratory disease in a national sam-ple: data from the second National Health and Nutrition Exa-mination Survey, 1976-80 (NHANES II). J Allergy Clin Immu-nol 1992
  34. 579–88. 33.Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates tran-sepithelial allergen delivery by disruption of tight junctions.J Clin Invest 1999
  35. 123–33. 34.Pichavant M, Charbonnier AS, Taront S, et al. Asthmatic bronc-hial epithelium activated by the proteolytic allergen Der p 1increases selective dendritic cell recruitment. J Allergy ClinImmunol 2005
  36. 771–78. 35.Lintner TJ, Brame KA. The e Kaynaklar 1.Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhini-tis and its impact on asthma. J Allergy Clin Immunol 2001
  37. 108 (Suppl. 5): S147–S334. 2.International Consensus Report on Diagnosis and Manage-ment of Rhinitis. International Rhinitis Management WorkingGroup. Allergy 1994
  38. 49 (Suppl. 19): 1–34. 3.Fokkens WJ. Thoughts on the pathophysiology of nonallergicrhinitis. Curr Allergy Asthma Rep 2002
  39. 203–209. 4.Fokkens W, Lund V, Bachert C, et al. EAACI position paperon rhinosinusitis and nasal polyp’s executive summary. Allergy2005
  40. 583–601. 5.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998
  41. 463–68. 6.Van-Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. EAACIPosition paper. Allergy 2000
  42. 116–34. 7.Bousquet J, Khaltaev N, Cruzz AA, et al. Allergic Rhinitis andIts Impact on Asthma (ARIA) 2008 update (in collaborationwith the World Health Organization, GA(2)LEN and AllerGen).Allergy 2008
  43. : 8-160.8.Tuncer A, Yüksel H. Ulusal Alerji Tanı ve tedavi Rehberi. Ulu-sal Allerji ve İmmunoloji Derneği, 2012. 9.Dykewicz MS, Fineman S. Executive summary of Joint TaskForce Practice Parameters on Diagnosis and Management ofRhinitis. Ann Allergy Asthma Immunol 1998
  44. 463–68. 10.Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol2003
  45. 111 (Suppl. 2): S520–S529. 11.van Cauwenberge P, Bachert C, Passalacqua G, et al. Con-sensus statement on the treatment of allergic rhinitis. Euro-pean Academy of Allergology and Clinical Immunology. Al-lergy 2000
  46. 116–34. 12.Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pol-lutants enhance rhinoconjunctivitis symptoms in pollen aller-gic individuals. Ann Allergy Asthma Immunol 2001
  47. 311–18. 13.Nascimento Silva M, Naspitz C, Sole D. Evaluation of qua-lity of life in children and teenagers with allergic rhinitis: adap-tation and validation of the Rhinoconjunctivitis Quality of LifeQuestionnaire (RQLQ). Allergol Immunopathol (Madr) 2001
  48. 111–18. 14.Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validati-on of the standardized version of the Rhinoconjunctivitis Qua-lity of Life Questionnaire. J Allergy Clin Immunol 1999
  49. 364–69. 15.Spector SL, Nicklas RA, Chapman JA, et al. Symptom seve-rity assessment of allergic rhinitis: part 1. Ann Allergy Asth-ma Immunol 2003
  50. 105–14. 16.Clement PA, Gordts F. Consensus report on acoustic rhino-metry and rhinomanometry. Rhinology 2005
  51. 169–79. 17.Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxi-de in objective evaluation of chronic rhinosinusitis therapy.Allergy 2006
  52. 717–24. 18.Litvyakova LI, Baraniuk JN. Nasal provocation testing: a re-view. Ann Allergy Asthma Immunol 2001
  53. 355–64. 19.Moll B, Klimek L, Eggers G, Mann W. Comparison of olfac-tory function in patients with seasonal and perennial allergicrhinitis. Allergy 1998
  54. 297–301. 20.Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according toARIA guidelines. Allergy 2007
  55. 367–72. 21.Yorgancıoğlu A, Özdemir C, Kalaycı Ö, et al
  56. WHO Collabo-rating Center on Asthma and Rhinitis. [ARIA (Allergic Rhi-nitis and its Impact on Asthma) achievements in 10 years andfuture needs]. Tuberk Toraks 2012
  57. Barnes K, Marsh D. The genetics and complexity of allergyand asthma. Immunol Today 1998
  58. 325–32. 23.Kurz T, Altmueller J, Strauch K, et al. A genome-wide scre-en on the genetics of atopy in a multiethnic European popu-lation reveals a major atopy locus on chromosome 3q21.3. Al-lergy 2005
  59. 192–99. 24.Strachan DP. Is allergic disease programmed in early life? [edi-torial
  60. comment]. Clin Exp Allergy 1994
  61. 603–605. 25.von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. In-creasing prevalence of hay fever and atopy among childrenin Leipzig, East Germany. Lancet 1998
  62. 862–66. 26.Stazi MA, Sampogna F, Montagano G, Grandolfo ME, CouilliotMF, Annesi Maesano I. Early life factors related to clinical ma-nifestations of atopic disease but not to skin prick test positivityin young children. Pediatr Allergy Immunol 2002
  63. 105–12. 27.Bjorksten F, Suoniemi I, Koski V. Neonatal birch pollen con-tact and subsequent allergy to birch pollen. Clin Allergy 1980
  64. 585–91. 28.Tedeschi A, Barcella M, Bo GA, Miadonna A. Onset of allergyand asthma symptoms in extra European immigrants to Mi-lan, Italy: possible role of environmental factors. Clin Exp Al-lergy 2003
  65. 449–54. 29.Stewart GA, Thompson PJ. The biochemistry of common ae-roallergens. Clin Exp Allergy 1996
  66. 1020–44. 30.Boulet LP, Turcotte H, Laprise C, et al. Comparative degreeand type of sensitization to common indoor and outdoor al-lergens in subjects with allergic rhinitis and/or asthma. ClinExp Allergy 1997
  67. 52–59. 31.Braun-Fahrlander C, Wuthrich B, Gassner M, et al. Valida-tion of a rhinitis symptom questionnaire (ISAAC core questi-ons) in a population of Swiss school children visiting the scho-ol health services. SCARPOL team. Swiss Study on Childho-od Allergy and Respiratory Symptom with respect to Air Pol-lution and Climate. International Study of Asthma and Aller-gies in Childhood. Pediatr Allergy Immunol 1997
  68. 75–82. 32.Gergen PJ, Turkeltaub PC. The association of individual al-lergen reactivity with respiratory disease in a national sam-ple: data from the second National Health and Nutrition Exa-mination Survey, 1976-80 (NHANES II). J Allergy Clin Immu-nol 1992
  69. 579–88. 33.Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates tran-sepithelial allergen delivery by disruption of tight junctions.J Clin Invest 1999
  70. 123–33. 34.Pichavant M, Charbonnier AS, Taront S, et al. Asthmatic bronc-hial epithelium activated by the proteolytic allergen Der p 1increases selective dendritic cell recruitment. J Allergy ClinImmunol 2005
  71. 771–78. 35.Lintner TJ, Brame KA. The e